An open-label, randomized study comparing the efficacy and safety of piperacillin/tazobactam and ampicillin/sulbactam administered intravenously in the empirical treatment of foot infections in diabetic patients
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2007
At a glance
- Drugs Piperacillin/tazobactam; Sulbactam/ampicillin
- Indications Bacterial infections; Diabetic foot ulcer; Skin and soft tissue infections
- Focus Therapeutic Use
- 09 Oct 2007 Status changed from in progress to completed.
- 08 Oct 2005 New trial record.